About Arbutus Biopharma Corp
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: CA
- Website: https://www.arbutusbio.com/
Frequently Asked Questions
What is the 52-week range for ABUS?
The 52-week high is $5.45 and the 52-week low is $3.5.
What is the P/E ratio for ABUS?
The Price to Earnings (P/E) ratio is 5.75.
What is the dividend yield for ABUS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is 90.98%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is 84.23%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 12.08.
Analyst Recommendation Trends
Wall Street analyst consensus for ABUS over the last few months:
Latest ABUS News
Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the final results of its tender offer (the “Offer”) to purchase for cancellation up to US$230 million in value of its common shares (the “Shares”). The Offer proceeded by way of a modified Dutch auction, which had a tender price range from US$5.00 per Share to US$5.75 per Share, and
Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
WARMINSTER, Pa., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today announced the preliminary results of its tender offer (the “Offer”) to purchase for cancellation up to US$230 million in value of its common shares (the “Shares”). The Offer proceeded by way of a modified Dutch auction, which had a tender price range from US$5.00 per Share to US$5.75 per Shar
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
Roivant Sciences: Diverse Exposure To Biotech Niches Through Vants
Roivant Sciences outlook: LISRAYA approval strengthens revenue, while brepocitinib and mosliciguat could expand immunology/pulmonary franchises. Click for more on ROIV stock.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-18 | Androski Lindsay | -10,456 | - | - |
| 2026-09-18 | Androski Lindsay | -116,408 | - | - |
| 2026-09-18 | Androski Lindsay | -82,527 | $5.07 | $418,412 |
| 2026-09-18 | Androski Lindsay | +10,456 | $4.39 | $45,902 |
| 2026-09-18 | Androski Lindsay | +116,408 | $3.2 | $372,506 |
| 2026-09-18 | Nguyen Tuan | -27,475 | - | - |
| 2026-09-18 | Nguyen Tuan | -265,625 | - | - |
| 2026-09-18 | Nguyen Tuan | -206,637 | $5.07 | $1,047,650 |
| 2026-09-18 | Nguyen Tuan | +27,475 | $4.39 | $120,615 |
| 2026-09-18 | Nguyen Tuan | +265,625 | $3.49 | $927,031 |
| 2026-09-18 | Sawhney Roger | -78,800 | - | - |
| 2026-09-18 | Sawhney Roger | -52,533 | - | - |
| 2026-09-18 | Sawhney Roger | -100,508 | $5.07 | $509,576 |
| 2026-09-18 | Sawhney Roger | +78,800 | $4.24 | $334,112 |
| 2026-09-18 | Sawhney Roger | +52,533 | $3.34 | $175,460 |
| 2026-09-18 | Beardsley Robert A | -78,800 | - | - |
| 2026-09-18 | Beardsley Robert A | -52,533 | - | - |
| 2026-09-18 | Beardsley Robert A | -99,057 | $5.07 | $502,219 |
| 2026-09-18 | Beardsley Robert A | +78,800 | $4.24 | $334,112 |
| 2026-09-18 | Beardsley Robert A | +52,533 | $3.2 | $168,106 |
| 2026-06-08 | Sawhney Roger | +78,800 | - | - |
| 2026-06-08 | Beardsley Robert A | +78,800 | - | - |
| 2026-02-02 | Nguyen Tuan | +188,400 | - | - |
| 2026-02-02 | Nguyen Tuan | +73,500 | - | - |
| 2026-02-02 | Androski Lindsay | +71,700 | - | - |
| 2026-02-02 | Androski Lindsay | +28,000 | - | - |